GKIM
OFIX icon

GW&K Investment Management’s Orthofix Medical OFIX Stock Holding History

GW&K Investment Management’s Portfolio OFIX Stock Details OFIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-169,780
Closed -$2.18M – 945
2023
Q3 		$2.18M Sell
169,780
-3,314
-2% -$59.6K 0.02% 306
2023
Q2 		$3.13M Sell
173,094
-2,569
-1% -$48K 0.03% 296
2023
Q1 		$2.94M Buy
+175,663
New +$3.44M 0.03% 290

Other funds holding OFIX

RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ECM
Engine Capital Management New York $1.03B AUM 4.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

GW&K Investment Management's OFIX Position: Q4 2023 in Review

GW&K Investment Management sold out of Orthofix Medical (OFIX) in Q4 2023, closing a stake of 169,780 shares — an estimated $2.18M sold.

GW&K Investment Management first reported a position in OFIX in Q1 2023 and held it in 3 quarters. The position peaked at $3.13M in Q2 2023. 156 funds tracked by Wall St. Rank hold OFIX as of Q4 2023.

  • GW&K Investment Management reported no remaining Orthofix Medical position as of Q4 2023 after selling out during the quarter.
  • GW&K Investment Management sold 169,780 Orthofix Medical shares in Q4 2023, an estimated $2.18M.
  • GW&K Investment Management first reported a position in Orthofix Medical in Q1 2023 and held it in 3 quarters.
  • GW&K Investment Management's Orthofix Medical position peaked at $3.13M in Q2 2023.
  • 156 funds tracked by Wall St. Rank held Orthofix Medical as of Q4 2023.

Based on GW&K Investment Management's 13F filing for Q4 2023, filed 9 Feb 2024.